With the generous support from VeloSano Bike to Cure, the Case Comprehensive Cancer Center provides seed funding for highly innovative and potentially impactful proposals that will generate key data for larger, nationally competitive grants.
2017 VeloSano Pilot Awardees
We are pleased to announce the recipients of the Case Comprehensive Cancer Center 2017 VeloSano Pilot Awards, made possible by generous support from VeloSano Bike to Cure 2016.
Each awardee will receive $50,000 in seed funding to support the initiation of novel projects aligned with one or more of our seven Research Programs.
Junran Zhang, MD, PhD
Assistant Professor, Radiation Oncology, CWRU/UH
"Novel approaches for targeting PPP2R2A defective cancer cells by ATR and CHK1 inhibitor"
John Wang, PhD
Professor, Genetics and Genome Sciences, CWRU and Co-Leader, Cancer Genetics Program, Case CCC
"Develop GPT2 inhibitors to target PI3KCA-mutated colorectal cancers"
Lan Zhou, MD, PhD
Assistant Professor, Pathology, CWRU/UH
"HES1-loss mediates Immune-suppressive microenvironment in serrated pathway of colon carcinogenesis"
Alvin Schmaier, MD
Professor, Hematology and Oncology, CWRU/UH
"Tyrosine kinase inhibitors and cardiovascular events in CML"
Mark Jackson, PhD
Associate Professor, Pathology, CWRU and Associate Director for Training and Education, Case CCC
"A high-throughput screen for inhibitors of cancer stem cell plasticity"
Youwei Zhang, PhD
Associate Professor, Pharmacology, CWRU
"Roles of UbcH7 in tumorigenesis and therapy response"
Jill Barnholtz-Sloan, PhD
Professor, Oncology, CWRU and Associate Director for Bioinformatics, Case CCC
"Hematologic biomarkers of treatment response & recurrence in patients with glioblastoma"